Abstract
Half-sandwich mono and dinuclear ruthenium, rhodium and iridium complexes (1–9) have been synthesized with ligands L1 {N'-(9H-fluoren-9-ylidene) thiophene-2-carbohydrazide}, L2 {N'-(9H-fluoren-9-ylidene)-3-methoxybenzohydrazide} and L3 {N'-(9H-fluoren-9-ylidene) isonicotinohydrazide}. The neutral mononuclear bidentate complexes were obtained by treatment of the hydrazone ligands (L1, L2) with metal precursors [(arene)MCl2]2 (arene = p-cymene, Cp*; M = Ru, Rh and Ir) in a 1:2 ratio. Reactions of [(arene)MCl2]2 with L3 in both 1:2 and 1:1 metal dimer to ligand ratios have yielded neutral dinuclear complexes where L3 acts as a tridentate ditopic ligand. Single-crystal X-ray diffraction studies have determined the solid-state structures of eight complexes (1–7, 9). In vitro antibacterial activities of the synthesized ligands and complexes were evaluated against human pathogenic bacteria. These compounds were evaluated for their in vitro antioxidant activity by using the DPPH assay. The binding capacity of complex 2 to SM-DNA was elucidated using fluorescence spectroscopy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.